{"id":"https://openalex.org/W2890619772","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","title":"Relationship between tumor infiltrating lymphocytes (Tils) and neutrophil-lymphocyte ratio (NLR) as a prognostic factor in patients with advanced non-small cell lung cancer.","display_name":"Relationship between tumor infiltrating lymphocytes (Tils) and neutrophil-lymphocyte ratio (NLR) as a prognostic factor in patients with advanced non-small cell lung cancer.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2890619772","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","mag":"2890619772"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.e20617","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069883019","display_name":"Eduardo Richardet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Eduardo Richardet","raw_affiliation_strings":["Instituto Oncologico Cordoba, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Oncologico Cordoba, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101600923","display_name":"Patricia Andrea Hernandez","orcid":"https://orcid.org/0000-0002-2319-3525","observed_orcids":["https://orcid.org/0000-0002-2319-3525"]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Patricia Andrea Hernandez","raw_affiliation_strings":["IONC, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IONC, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081758087","display_name":"Martin Eduardo Richardet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Martin Eduardo Richardet","raw_affiliation_strings":["Oncology Institute of Cordoba, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Cordoba, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110475741","display_name":"Matias Nicolas Cortes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Matias Nicolas Cortes","raw_affiliation_strings":["Instituto Oncologico De Cordoba, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Oncologico De Cordoba, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008711852","display_name":"Matias Molina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Matias Molina","raw_affiliation_strings":["IONC, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IONC, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112216001","display_name":"Luciana Paola Acosta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Luciana Paola Acosta","raw_affiliation_strings":["IONC, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IONC, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018386485","display_name":"Luciano Salvador Dicalbo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Luciano Dicalbo","raw_affiliation_strings":["IONC, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IONC, Cordoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033792519","display_name":"Rocio Paola Villavicencio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130110","display_name":"Instituto Oncol\u00f3gico de C\u00f3rdoba","ror":"https://ror.org/02hscsw24","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210130110"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Rocio Villavicencio","raw_affiliation_strings":["IONC, C\u00f3rdoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IONC, C\u00f3rdoba, Argentina;","institution_ids":["https://openalex.org/I4210130110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021349525","display_name":"Evelin Pets","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evelin Pets","raw_affiliation_strings":["Martin Paradelo, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Martin Paradelo, Cordoba, Argentina;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007434733","display_name":"Mart\u00edn Paradelo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Paradelo","raw_affiliation_strings":["Martin Paradelo, Cordoba, Argentina;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Martin Paradelo, Cordoba, Argentina;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"e20617","last_page":"e20617"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9359999895095825},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9890000224113464},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.7250000238418579},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8059999942779541},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5680000185966492},{"id":"https://openalex.org/keywords/pretreatment-biomarkers","display_name":"pretreatment biomarkers","score":0.7059999704360962},{"id":"https://openalex.org/keywords/lymphocytic-infiltration","display_name":"lymphocyte infiltration","score":0.453000009059906},{"id":"https://openalex.org/keywords/neutrophils","display_name":"neutrophils","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9218382835388184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7287424206733704},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7246088981628418},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.6530977487564087},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5654325485229492},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.560677170753479},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5308884978294373},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4772615134716034},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4644121825695038},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4582080841064453},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4495479166507721},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4385095238685608},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4246596693992615},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.34412696957588196},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21325185894966125},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.09876695275306702},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.e20617","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e20617","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2530116791","https://openalex.org/W2285613380","https://openalex.org/W4321768390","https://openalex.org/W4393092749","https://openalex.org/W2075691289","https://openalex.org/W2997716862","https://openalex.org/W4396645242","https://openalex.org/W3023682204","https://openalex.org/W4238109304","https://openalex.org/W625329317"],"abstract_inverted_index":{"e20617":[0],"Background:":[1],"Association":[2],"between":[3,72,108],"cancer":[4,48,73],"and":[5,62,74,89,96,114,116,123,138,162,195,219,235,298,334],"inflammation":[6,76],"is":[7,11,103],"extensively":[8],"studied.":[9,80],"There":[10],"a":[12,16,25,41,59,189,196],"greater":[13],"probability":[14],"that":[15,53,332],"tumor":[17,36,254],"arises":[18],"at":[19],"sites":[20],"of":[21,35,111,126,128,153,192,199,243,259,273,285,295,308,342,369],"chronic":[22],"inflammation.":[23],"In":[24,327],"recent":[26],"study":[27,51,125],"in":[28,44,252,323,348],"our":[29],"institution,":[30],"we":[31,330,358],"demonstrated":[32],"the":[33,86,106,109,151,154,178,213,220,244,262,286,299,340,362,365,371],"role":[34],"infiltrating":[37],"lymphocytes":[38],"(TILs)":[39],"as":[40,158,169],"prognostic":[42,321],"factor":[43],"non-small":[45],"cell":[46],"lung":[47],"(NSCLC).":[49],"Our":[50,100],"showed":[52,351],"patients":[54,127,134,183,205,241,246,264,280,288,324,349],"with":[55,67,135,188,247,256,281,289,302,325,339,344,364],"present":[56,170,282],"TILs":[57,166,251,269,283],"had":[58,184,206,250,270,292,305],"higher":[60],"OS":[61,191,215,234,258,272,294,307,333],"PFS":[63,198,222,335],"compared":[64],"to":[65,84,92,104,119,150,360],"those":[66],"no":[68,303],"TILs.":[69],"The":[70,202],"relation":[71,91],"systemic":[75],"has":[77],"been":[78],"less":[79],"We":[81],"primarily":[82],"aim":[83],"investigate":[85],"NLR":[87,115,155,185,208,315,353,363],"pre-treatment":[88,207,316],"its":[90,117],"overall":[93],"survival":[94,98],"(OS)":[95],"progression-free":[97],"(PFS).":[99],"secondary":[101],"endpoint":[102],"establish":[105],"relationship":[107],"state":[110],"lymphocyte":[112],"infiltration":[113],"association":[118],"survival.":[120],"Methods:":[121],"Retrospective":[122],"analytical":[124],"Instituto":[129],"Oncol\u00f3gico":[130],"de":[131],"C\u00f3rdoba.":[132],"165":[133],"stage":[136],"IIIB":[137],"IV":[139],"NSCLC":[140],"were":[141,144,167,175,228,336],"analyzed.":[142],"Patients":[143],"split":[145],"into":[146],"two":[147],"groups":[148],"according":[149],"value":[152,341],"(pre":[156],"established":[157],"low:":[159],"<":[160,186],"3.44":[161],"high:":[163],"\u2265":[164],"3.44).":[165],"classified":[168],"or":[171,367],"absent.":[172],"Survival":[173],"curves":[174],"calculated":[176],"using":[177],"Kaplan-Meier":[179],"method.":[180],"Results:":[181],"88":[182,245],"3.44,":[187],"median":[190,197,214,221],"12.8":[193],"months":[194,218,275,297,310],"7.7":[200],"months.":[201,225],"remaining":[203,300],"77":[204,287],">":[209,354],"3.44.":[210,355],"Among":[211],"them":[212],"was":[216,223],"8.8":[217],"5.3":[224],"These":[226],"differences":[227],"statistically":[229,375],"significant":[230],"(p:":[231],"0.001":[232,237],"for":[233,238],"p:":[236],"PFS).":[239],"52":[240],"(out":[242,284],"low":[248],"NLR)":[249,291],"their":[253],"samples":[255],"an":[257,271,293,306,352],"11":[260],"months;":[261],"36":[263],"who":[265,350],"did":[266],"not":[267,374],"have":[268],"10":[274],"(p":[276,311],"=":[277,312],"0.15).":[278],"40":[279],"high":[290],"10.4":[296],"37":[301],"TILs,":[304,370],"7":[309],"0.16).":[313],"Conclusions:":[314],"measurements":[317],"can":[318],"provide":[319],"important":[320],"outcomes":[322,347],"NSCLC.":[326],"this":[328],"study,":[329],"found":[331],"significantly":[337,345],"associated":[338],"NLR,":[343],"lower":[346],"But":[356],"when":[357],"try":[359],"relate":[361],"presence":[366],"absence":[368],"results":[372],"are":[373],"significant.":[376]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-09-27T00:00:00"}